Skip to content

VISTAGEN THERAPEUTICS, INC.: 10-K filed 2013-07-18

What VISTAGEN THERAPEUTICS, INC. reported in its annual report filed 2013-07-18 (fiscal FY 2012): 31 published measures, 175 facts as tagged in accession 0001415889-13-001409.

This filing

Form
10-K (annual report)
Filed
2013-07-18
Fiscal period
fiscal FY 2012
Accession
0001415889-13-001409 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VISTAGEN THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-03-31881,500USD
At 2012-03-31341,600USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-03-3113,437,900USD
At 2012-03-316,047,200USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-03-31-12,556,400USD
At 2012-03-31-5,705,600USD
At 2011-03-31-32,884,500USD
At 2010-03-31-26,337,100USD
At 2009-03-31-26,683,900USD
At 2008-03-31-22,167,000USD
At 2007-03-31-17,447,600USD
At 2006-03-31-16,502,100USD
At 2005-03-31-14,739,900USD
At 2004-03-31-13,688,900USD
At 2003-03-31-4,947,600USD
At 2002-03-31-4,583,300USD
At 2001-03-31-2,511,200USD
At 2000-03-31-844,100USD
At 1999-03-31-225,500USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-03-31638,100USD
At 2012-03-3181,000USD
At 2011-03-31139,300USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-3,770,000USD90
2012-04-01 to 2013-03-31-12,886,700USD365
1998-05-26 to 2013-03-31-67,669,200USD5424
2012-10-01 to 2012-12-31-5,335,000USD92
2012-07-01 to 2012-09-30-1,956,000USD92
2012-04-01 to 2012-06-30-1,826,000USD91
2012-01-01 to 2012-03-31-3,043,000USD91
2011-04-01 to 2012-03-31-12,209,500USD366
2011-10-01 to 2011-12-31-4,500,000USD92
2011-07-01 to 2011-09-30-2,256,000USD92
2011-04-01 to 2011-06-30-2,411,000USD91
2010-04-01 to 2011-03-31-9,482,200USD365
2009-04-01 to 2010-03-31-4,124,500USD365
2008-04-01 to 2009-03-31-4,696,200USD365
2007-04-01 to 2008-03-31-5,446,700USD366
2006-04-01 to 2007-03-31-1,999,800USD365
2005-04-01 to 2006-03-31-1,772,100USD365
2004-04-01 to 2005-03-31-1,082,800USD365
2003-04-01 to 2004-03-31-8,755,500USD366
2002-04-01 to 2003-03-31-502,600USD365
2001-04-01 to 2002-03-31-2,113,000USD365
2000-04-01 to 2001-03-31-1,809,000USD365
1999-04-01 to 2000-03-31-700,000USD366
1998-05-26 to 1999-03-31-230,900USD310

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-04-01 to 2013-03-31-3,463,200USD365
1998-05-26 to 2013-03-31-20,971,700USD5424
2011-04-01 to 2012-03-31-3,565,800USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-04-01 to 2013-03-31200,400USD365
1998-05-26 to 2013-03-3116,370,200USD5424
2012-04-01 to 2012-06-30200,000USD91
2012-01-01 to 2012-03-31469,000USD91
2011-04-01 to 2012-03-311,342,200USD366
2011-10-01 to 2011-12-312,000USD92
2011-07-01 to 2011-09-30316,000USD92
2011-04-01 to 2011-06-30555,000USD91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-04-01 to 2013-03-314,155,700USD365
1998-05-26 to 2013-03-3122,426,000USD5424
2011-04-01 to 2012-03-313,539,900USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-04-01 to 2013-03-31-135,400USD365
1998-05-26 to 2013-03-31-816,200USD5424
2011-04-01 to 2012-03-31-32,400USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-03-31-67,669,200USD
At 2012-03-31-54,782,500USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-01-01 to 2013-03-3120,236,491shares90
2012-04-01 to 2013-03-3118,108,444shares365
2012-10-01 to 2012-12-3118,292,301shares92
2012-07-01 to 2012-09-3017,094,833shares92
2012-04-01 to 2012-06-3016,842,655shares91
2012-01-01 to 2012-03-3116,542,717shares91
2011-04-01 to 2012-03-3114,736,651shares366
2011-10-01 to 2011-12-3116,035,861shares92
2011-07-01 to 2011-09-3015,241,904shares92
2011-04-01 to 2011-06-3011,105,854shares91

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-0.19USD/shares90
2012-04-01 to 2013-03-31-1.27USD/shares365
2012-10-01 to 2012-12-31-0.85USD/shares92
2012-07-01 to 2012-09-30-0.11USD/shares92
2012-04-01 to 2012-06-30-0.11USD/shares91
2012-01-01 to 2012-03-31-0.18USD/shares91
2011-04-01 to 2012-03-31-0.83USD/shares366
2011-10-01 to 2011-12-31-0.28USD/shares92
2011-07-01 to 2011-09-30-0.15USD/shares92
2011-04-01 to 2011-06-30-0.22USD/shares91

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-04-01 to 2013-03-313,700USD365
1998-05-26 to 2013-03-3120,500USD5424
2012-10-01 to 2012-12-31-2,000USD92
2012-04-01 to 2012-06-30-2,000USD91
2011-04-01 to 2012-03-311,600USD366
2011-04-01 to 2011-06-30-2,000USD91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-03-31180,700USD
At 2012-03-3174,500USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-04-01 to 2013-03-311,241,300USD365
1998-05-26 to 2013-03-315,595,600USD5424
2011-04-01 to 2012-03-311,591,300USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-1,471,000USD90
2012-04-01 to 2013-03-31-6,793,100USD365
1998-05-26 to 2013-03-31-51,389,800USD5424
2012-10-01 to 2012-12-31-1,919,000USD92
2012-07-01 to 2012-09-30-1,682,000USD92
2012-04-01 to 2012-06-30-1,721,000USD91
2012-01-01 to 2012-03-31-2,787,000USD91
2011-04-01 to 2012-03-31-9,043,400USD366
2011-10-01 to 2011-12-31-2,852,000USD92
2011-07-01 to 2011-09-30-1,805,000USD92
2011-04-01 to 2011-06-30-1,600,000USD91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-03-31671,800USD
At 2012-03-31238,100USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-03-31-309,000USD90
2012-04-01 to 2013-03-31-920,700USD365
1998-05-26 to 2013-03-31-10,362,200USD5424
2012-10-01 to 2012-12-31-235,000USD92
2012-07-01 to 2012-09-30-274,000USD92
2012-04-01 to 2012-06-30-103,000USD91
2012-01-01 to 2012-03-31-256,000USD91
2011-04-01 to 2012-03-31-1,893,200USD366
2011-10-01 to 2011-12-31-455,000USD92
2011-07-01 to 2011-09-30-451,000USD92
2011-04-01 to 2011-06-30-731,000USD91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-03-312,414,300USD
At 2012-03-313,182,500USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-03-311,353,700USD
At 2012-03-311,750,800USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-03-311,471,000USD90
2012-04-01 to 2013-03-316,993,500USD365
1998-05-26 to 2013-03-3167,760,000USD5424
2012-10-01 to 2012-12-311,919,000USD92
2012-07-01 to 2012-09-301,682,000USD92
2012-04-01 to 2012-06-301,921,000USD91
2012-01-01 to 2012-03-313,256,000USD91
2011-04-01 to 2012-03-3110,385,600USD366
2011-10-01 to 2011-12-312,854,000USD92
2011-07-01 to 2011-09-302,121,000USD92
2011-04-01 to 2011-06-302,155,000USD91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-03-31339,000USD90
2012-04-01 to 2013-03-313,430,800USD365
1998-05-26 to 2013-03-3129,555,700USD5424
2012-10-01 to 2012-12-311,120,000USD92
2012-07-01 to 2012-09-301,106,000USD92
2012-04-01 to 2012-06-30866,000USD91
2012-01-01 to 2012-03-311,828,000USD91
2011-04-01 to 2012-03-315,388,600USD366
2011-10-01 to 2011-12-311,306,000USD92
2011-07-01 to 2011-09-301,227,000USD92
2011-04-01 to 2011-06-301,028,000USD91

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-03-3159,266,000USD
At 2012-03-3152,539,500USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-03-31732,000USD
At 2012-03-31604,300USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-03-31-551,300USD
At 2012-03-31-529,800USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-03-3129,000USD
At 2012-03-3129,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-03-31342,900USD
At 2012-03-31657,300USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-04-01 to 2013-03-31-12,886,700USD365
1998-05-26 to 2013-03-31-67,669,200USD5424
2011-04-01 to 2012-03-31-12,209,500USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-03-311,132,000USD90
2012-04-01 to 2013-03-313,562,700USD365
1998-05-26 to 2013-03-3130,681,100USD5424
2012-10-01 to 2012-12-31799,000USD92
2012-07-01 to 2012-09-30576,000USD92
2012-04-01 to 2012-06-301,055,000USD91
2012-01-01 to 2012-03-311,428,000USD91
2011-04-01 to 2012-03-314,997,000USD366
2011-10-01 to 2011-12-311,548,000USD92
2011-07-01 to 2011-09-30894,000USD92
2011-04-01 to 2011-06-301,127,000USD91

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-04-01 to 2013-03-311,185,100USD365
1998-05-26 to 2013-03-313,985,100USD5424
2011-04-01 to 2012-03-312,679,200USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2013-03-31106,200USD365
2011-04-01 to 2012-03-31-64,000USD366

Inspect the source

Entity
VISTAGEN THERAPEUTICS, INC. / CIK 0001411685
Captured
2026-09-20T08:01:56.841Z
SEC response SHA-256
1d0d09c7b53b173e35f99fba8d3201ca751174b9bb70167acdba04307bebca91

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411685.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))